Promise and challenges of peptide-poly: ICLC vaccines for adult and pediatric gliomas

Authors :: Douglas M. Potter
Hideho Okada
Ronald L. Hamilton
Frank S. Lieberman
Lisa H. Butterfield
Andres M. Salazar
Ian F. Pollack
Source :: Journal for Immunotherapy of Cancer
Publication Year :: 2013
Publisher :: BioMed Central, 2013.
Abstract: Meeting abstracts We currently run phase I studies of subcutaneous vaccinations with synthetic peptides for glioma-associated antigen (GAA) epitopes emulsified in Montanide-ISA-51 and intramuscular administration of poly-ICLC in HLA-A2+ adult and pediatric patients with gliomas. Primary endpoints

Tools